AOD Update - News and Resources on Alcohol and Other Drugs Minnesota Department of Health sent this bulletin at 12/14/2023 10:00 AM CST AOD Update - December 2023 View this as a webpage December 14, 2023 Events and Announcements Opioid settlement webinar: Landscape and efforts to evaluate and maximize impact (Overdose Response Strategy) – Dec. 15 from 12 – 1 p.m. Risk factors for youth substance misuse (PTTC) – Jan. 9 from 10 – 11:30 a.m. Public health consequences of changes in the cannabis landscape (National Academies) – Jan. 11 Cannabis and public health - an overview for those who are new to this work (CannAct) – Jan. 29 from 5 - 7 p.m. Minnesota’s medical cannabis program adds new delivery method for patients (Minnesota Department of Health) New cannabis research center launches at UMN School of Public Health (University of Minnesota School of Public Health) Biden-Harris administration calls on housing community to help expand access to life-saving opioid overdose reversal medications like naloxone (SAMHSA) Data and Research 2022 National survey on drug use and health (NSDUH) releases (SAMHSA) Emergency department visits at Veteran’s Health Administration hospitals related to alcohol Intoxication: A ten-year retrospective (Science Direct) Clustering of smoking, alcohol consumption and weight gain in pregnancy: Prevalence, care preferences and associated factors (BMC Pregnancy and Childbirth) No evidence found that cannabis reduces long term opioid use, study shows (Science Daily) Genomic study links cannabis abuse to multiple health problems (Science Daily) Study identifies peptide as key mediator in heavy alcohol drinking (Science Daily) Combined use of alcohol and THC can affect rat brains, study finds (Science Daily) Alcohol Tennessee launches campaign to promote safe alcohol use during holidays (TN DSHS) Alcohol taxes aren't high enough, says World Health Organisation (Reuters) WHO technical manual on alcohol tax policy and administration (WHO) New Jersey approves alcohol delivery by DoorDash, Instacart (CBS News) Cannabis First director of UMN Cannabis Research Center on studying the impact of marijuana legalization in Minnesota (MPR News) New interactive evidence-based mapping tool gives policymakers more insight into highly concentrated cannabis products (Science Daily) Camden cannabis dispensary opens in a neighborhood pharmacy, thought to be the first of its kind (The Philadelphia Inquirer) Minnesota set to launch roadside impairment test for marijuana (Star Tribune) Cannabis use disorder increasing among veterans with psychiatric disorders (American Psychiatric Association) Does a loophole in Minnesota’s new recreational cannabis law permit the sale of higher potency cannabis flower by hemp retailers? (MinnPost) Opioids and Prescription Drugs U.S. opioid crisis worsened during COVID-19 pandemic (University of Minnesota School of Public Health) Evolving overdose crisis shakes previously effective treatments (KFF Health News) Overdose deaths have soared among pregnant people, study reveals (Washington Post) Sesame Street muppets help young kids affected by opioid epidemic (NPR) Opioid crisis may be driving surge in youth suicides (US News) Drug prevents fentanyl overdose for a month in monkeys (New Scientist) Tobacco and E-cigarettes Most young adults who use e-cigarettes have never smoked (JAMA Network) Young adults used less tobacco and alcohol after cannabis legalization (Forbes) White House delays decision on banning menthol cigarettes (The New York Times) Other Drugs Pharmacist verification of buprenorphine providers (SAMHSA) ‘A monster’: Super meth and other drugs push crisis beyond opioids (The New York Times) Psychedelic Medicine Psychedelic medicine task force (MN Department of Health) Could psychedelics be the future of mental health? (MPR) Psychedelic therapy is having a moment — here’s what you need to know (Healthline) Legal use of hallucinogenic mushrooms begins in Oregon (New York Times) Colorado voted to decriminalize psilocybin and other psychedelics (Time) Washington Psilocybin Services Act: A magical legislative solution for promoting benefits of psychedelic drugs (Reuters) MDMA-assisted therapy for post-traumatic stress disorder (Multidisciplinary Association for Psychedelic Studies, MAPS) Psilocybin (“magic mushrooms”) for treatment-resistant depression (Compass Pathways) Learn more by visiting the MDH Alcohol and Other Drugs website. Questions? Contact the Injury and Violence Prevention Section: health.injuryprevention@state.mn.us. Do you have news or resources to contribute to the next AOD Update? Send them to Kari Gloppen at kari.gloppen@state.mn.us. Manage Preferences | Unsubscribe | Help | health.state.mn.us